BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Macdonald DC, Nelson M, Bower M, Powles T. Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era. World J Gastroenterol 2008; 14(11): 1657-1663 [PMID: 18350596 DOI: 10.3748/wjg.14.1657] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Taylor LE, Swan T, Mayer KH. HIV coinfection with hepatitis C virus: evolving epidemiology and treatment paradigms. Clin Infect Dis. 2012;55 Suppl 1:S33-S42. [PMID: 22715212 DOI: 10.1093/cid/cis367] [Cited by in Crossref: 106] [Cited by in F6Publishing: 100] [Article Influence: 10.6] [Reference Citation Analysis]
2 Spartalis E, Damaskos C, Athanasiou A, Dimitroulis D. The impact of hepatitis C virus and human immunodeficiency virus coinfection on survival in patients with hepatocellular carcinoma. Ann Gastroenterol 2017;30:471. [PMID: 28655991 DOI: 10.20524/aog.2017.0149] [Reference Citation Analysis]
3 Lewin M, Gelu-simeon M, Ostos M, Boufassa F, Sobesky R, Teicher E, Meyer L, Fontaine H, Salmon-céron D, Samuel D, Seror O, Trinchet J, Duclos-vallée J. Imaging Features and Prognosis of Hepatocellular Carcinoma in Patients with Cirrhosis Who Are Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus. Radiology 2015;277:443-53. [DOI: 10.1148/radiol.2015141500] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
4 Gramenzi A, Tedeschi S, Cantarini MC, Erroi V, Tumietto F, Attard L, Calza L, Foschi FG, Caraceni P, Pavoni M, Cucchetti A, Bernardi M, Viale P, Verucchi G, Trevisani F. Outcome of hepatocellular carcinoma in human immunodeficiency virus-infected patients. Digestive and Liver Disease 2013;45:516-22. [DOI: 10.1016/j.dld.2012.12.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
5 Shariff MI, Cox IJ, Gomaa AI, Khan SA, Gedroyc W, Taylor-robinson SD. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Review of Gastroenterology & Hepatology 2014;3:353-67. [DOI: 10.1586/egh.09.35] [Cited by in Crossref: 197] [Cited by in F6Publishing: 194] [Article Influence: 24.6] [Reference Citation Analysis]
6 Merchante N, Merino E, López-Aldeguer J, Jover F, Delgado-Fernández M, Galindo MJ, Ortega E, Rivero A, Mínguez C, Romero-Palacios A, Padilla S, Márquez-Solero M, Amador C, Ríos-Villegas MJ, Téllez F, Portilla J, Pineda JA. Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain. Clin Infect Dis 2013;56:143-50. [PMID: 22955438 DOI: 10.1093/cid/cis777] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 5.5] [Reference Citation Analysis]
7 Bourcier V, Winnock M, Ait Ahmed M, Sogni P, Pambrun E, Poizot-Martin I, Chaffaut C, Chevret S, Trinchet JC, Salmon D; ANRS CO13 Hepavih study group., ANRS CO12 Cirvir study group. Primary liver cancer is more aggressive in HIV-HCV coinfection than in HCV infection. A prospective study (ANRS CO13 Hepavih and CO12 Cirvir). Clin Res Hepatol Gastroenterol 2012;36:214-21. [PMID: 22189509 DOI: 10.1016/j.clinre.2011.11.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
8 Reddy A, May E, Ehrinpreis M, Mutchnick M. Latent hepatitis B is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C. World J Gastroenterol 2013; 19(48): 9328-9333 [PMID: 24409059 DOI: 10.3748/wjg.v19.i48.9328] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
9 Helleberg M, Gerstoft J, Afzal S, Kronborg G, Larsen CS, Pedersen C, Bojesen SE, Nordestgaard BG, Obel N. Risk of cancer among HIV-infected individuals compared to the background population: impact of smoking and HIV. AIDS 2014;28:1499-508. [PMID: 24785952 DOI: 10.1097/QAD.0000000000000283] [Cited by in Crossref: 75] [Cited by in F6Publishing: 46] [Article Influence: 10.7] [Reference Citation Analysis]
10 Matthews PC, Geretti AM, Goulder PJ, Klenerman P. Epidemiology and impact of HIV coinfection with hepatitis B and hepatitis C viruses in Sub-Saharan Africa. J Clin Virol. 2014;61:20-33. [PMID: 24973812 DOI: 10.1016/j.jcv.2014.05.018] [Cited by in Crossref: 100] [Cited by in F6Publishing: 94] [Article Influence: 12.5] [Reference Citation Analysis]
11 Reekie J, Kosa C, Engsig F, Monforte AD, Wiercinska-drapalo A, Domingo P, Antunes F, Clumeck N, Kirk O, Lundgren JD, Mocroft A; for the EuroSIDA Study Group. Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies. Cancer 2010;116:5306-15. [DOI: 10.1002/cncr.25311] [Cited by in Crossref: 104] [Cited by in F6Publishing: 96] [Article Influence: 8.7] [Reference Citation Analysis]
12 Huang AJ, Núñez M. Outcomes in HIV/HBV-Coinfected Patients in the Tenofovir Era Are Greatly Affected by Immune Suppression. J Int Assoc Provid AIDS Care 2015;14:360-8. [PMID: 25999329 DOI: 10.1177/2325957415586258] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
13 Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379:1245-1255. [PMID: 22353262 DOI: 10.1016/s0140-6736(11)61347-0] [Cited by in Crossref: 2892] [Cited by in F6Publishing: 1689] [Article Influence: 289.2] [Reference Citation Analysis]
14 Kew MC. Hepatocellular carcinoma in African Blacks: Recent progress in etiology and pathogenesis. World J Hepatol 2010; 2(2): 65-73 [PMID: 21160975 DOI: 10.4254/wjh.v2.i2.65] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
15 De Nardo P, Viscione M, Corpolongo A, Bellagamba R, Vennarecci G, Ettorre GM, Gentilotti E, Tommasi C, Nicastri E. Treatment of Recurrent Hepatocellular Carcinoma with Sorafenib in a HIV/HCV Co-Infected patient in HAART: A Case Report. Infect Agent Cancer 2012;7:15. [PMID: 22741810 DOI: 10.1186/1750-9378-7-15] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
16 Parikh N, Nonnemacher MR, Pirrone V, Block T, Mehta A, Wigdahl B. Substance abuse, HIV-1 and hepatitis. Curr HIV Res 2012;10:557-71. [PMID: 22973853 DOI: 10.2174/157016212803306023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
17 Gobert A, Mounier N, Lavole A, Poizot-Martin I, Spano JP. [HIV-related malignancies: state of art]. Bull Cancer 2014;101:1020-9. [PMID: 25418594 DOI: 10.1684/bdc.2014.2032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
18 Skagen C, Lucey M, Said A. Liver transplantation: an update 2009: . Current Opinion in Gastroenterology 2009;25:202-8. [DOI: 10.1097/mog.0b013e3283299652] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
19 Vaccher E, Serraino D, Carbone A, De Paoli P. The evolving scenario of non-AIDS-defining cancers: challenges and opportunities of care. Oncologist 2014;19:860-7. [PMID: 24969164 DOI: 10.1634/theoncologist.2014-0024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
20 Venkataramani M, Hutton N, Colombani P, Anders RA, Agwu AL. Hepatocellular carcinoma in a teenager with perinatally acquired HIV Infection without hepatitis B or C coinfection: a case report. AIDS Patient Care STDS 2010;24:693-6. [PMID: 20969466 DOI: 10.1089/apc.2010.0038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
21 Bruyand M, Dabis F, Vandenhende M, Lazaro E, Neau D, Leleux O, Geffard S, Morlat P, Chêne G, Bonnet F. HIV-induced immune deficiency is associated with a higher risk of hepatocarcinoma, ANRS CO3 Aquitaine Cohort, France, 1998–2008. Journal of Hepatology 2011;55:1058-62. [DOI: 10.1016/j.jhep.2011.02.017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
22 Corvalan AH. Early diagnosis of hepatocellular carcinoma by microRNAs: shining a light from the genome's "dark matter". Dig Dis Sci 2012;57:2737-9. [PMID: 23014845 DOI: 10.1007/s10620-012-2384-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
23 Malfitano A, Barbaro G, Barbarini G. Ongoing change in the treatment of HIV-associated malignancies in the HAART era. Expert Rev Clin Pharmacol 2009;2:283-93. [PMID: 24410706 DOI: 10.1586/ecp.09.1] [Reference Citation Analysis]
24 Polesel J, Franceschi S, Suligoi B, Crocetti E, Falcini F, Guzzinati S, Vercelli M, Zanetti R, Tagliabue G, Russo A, Luminari S, Stracci F, De Lisi V, Ferretti S, Mangone L, Budroni M, Limina RM, Piffer S, Serraino D, Bellù F, Giacomin A, Donato A, Madeddu A, Vitarelli S, Fusco M, Tessandori R, Tumino R, Piselli P, Dal Maso L. Cancer incidence in people with AIDS in Italy. Int J Cancer 2010;127:1437-45. [DOI: 10.1002/ijc.25153] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
25 Dimitroulis D, Valsami S, Spartalis E, Pikoulis E, Kouraklis G. Hepatocellular carcinoma in patients co-infected with hepatitis C virus and human immunodeficiency virus. World J Hepatol 2013; 5(6): 323-327 [PMID: 23805356 DOI: 10.4254/wjh.v5.i6.323] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
26 Kew MC. Hepatitis B virus / human immunodeficiency virus co-infection and its hepatocarcinogenic potential in sub-saharan black africans. Hepat Mon 2012;12:e7876. [PMID: 23166538 DOI: 10.5812/hepatmon.7876] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
27 Chelis L, Ntinos N, Souftas V, Deftereos S, Xenidis N, Chamalidou E, Maltezos E, Kakolyris S. Complete response after sorafenib therapy for hepatocellular carcinoma in an HIV-HBV co infected patient: Possible synergy with HAART ? A case report. Med Oncol. 2011;28 Suppl 1:S165-S168. [PMID: 20809183 DOI: 10.1007/s12032-010-9669-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
28 Zhang YY, Xia HH. Novel therapeutic approaches for hepatocellulcar carcinoma: fact and fiction. World J Gastroenterol 2008;14:1641-2. [PMID: 18350592 DOI: 10.3748/wjg.14.1641] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
29 Okeke E, Mark Davwar P, Mullen B, Duguru M, Agbaji O, Sagay A, Murphy R, Hawkins C. The impact of HIV on hepatocellular cancer survival in Nigeria. Trop Med Int Health 2021;26:335-42. [PMID: 33244817 DOI: 10.1111/tmi.13532] [Reference Citation Analysis]
30 Frassetto LA, Tan-Tam C, Stock PG. Renal transplantation in patients with HIV. Nat Rev Nephrol 2009;5:582-9. [PMID: 19776780 DOI: 10.1038/nrneph.2009.140] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
31 Harbell J, Terrault NA, Stock P. Solid organ transplants in HIV-infected patients. Curr HIV/AIDS Rep 2013;10:217-25. [PMID: 23893004 DOI: 10.1007/s11904-013-0170-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
32 Di Benedetto F, D'Amico G, De Ruvo N, Cocchi S, Montalti R, Cautero N, Guerrini GP, Ballarin R, Spaggiari M, Tarantino G, Baisi B, Cappelli G, Codeluppi M, Gerunda GE. Combined liver-kidney transplantation in patients infected with human immunodeficiency virus. Transpl Infect Dis 2011;13:501-6. [PMID: 21414117 DOI: 10.1111/j.1399-3062.2011.00622.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
33 Forner A, Reig M, Varela M, Burrel M, Feliu J, Briceño J, Sastre J, Martí-Bonmati L, Llovet JM, Bilbao JI, Sangro B, Pardo F, Ayuso C, Bru C, Tabernero J, Bruix J. [Diagnosis and treatment of hepatocellular carcinoma. Update consensus document from the AEEH, SEOM, SERAM, SERVEI and SETH]. Med Clin (Barc) 2016;146:511.e1-511.e22. [PMID: 26971984 DOI: 10.1016/j.medcli.2016.01.028] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
34 Hearn B, Chasan R, Bichoupan K, Suprun M, Bagiella E, Dieterich DT, Perumalswami P, Branch AD, Huprikar S. Low adherence of HIV providers to practice guidelines for hepatocellular carcinoma screening in HIV/hepatitis B coinfection. Clin Infect Dis 2015;61:1742-8. [PMID: 26240206 DOI: 10.1093/cid/civ654] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
35 Murala S, Alli V, Kreisel D, Gelman AE, Krupnick AS. Current status of immunotherapy for the treatment of lung cancer. J Thorac Dis 2010;2:237-44. [PMID: 22263052 DOI: 10.3978/j.issn.2072-1439.2010.11.6] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
36 Negri F, Missale G, Antoni AD, Porta C. Hepatocellular cancer therapy in patients with HIV infection: Disparities in cancer care, trials enrolment, and cancer-related research. Transl Oncol 2021;14:101153. [PMID: 34144349 DOI: 10.1016/j.tranon.2021.101153] [Reference Citation Analysis]
37 Kew MC, Smuts H, Stewart A. Does HIV Infection Enhance the Hepatocarcinogenic Potential of Chronic Hepatitis B Virus Infection? JAIDS Journal of Acquired Immune Deficiency Syndromes 2010;53:413-4. [DOI: 10.1097/qai.0b013e3181ba390f] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
38 Benedetto ND, Peralta M, Alvarez E, Schroder MT, Estepo C, Paz S, Fainboim H. Incidence of hepatocellular carcinoma in hepatitis C cirrhotic patients with and without HIV infection: a cohort study, 1999-2011. Annals of Hepatology 2014;13:38-44. [DOI: 10.1016/s1665-2681(19)30902-0] [Cited by in Crossref: 8] [Article Influence: 1.0] [Reference Citation Analysis]
39 Cenderello G, Pontali E, Cassola G, Torresin A. Could anti-HCV treatment prevent recurrence of hepatocellular carcinoma in HIV-infected patients? Two case reports. Infection 2013;41:199-202. [PMID: 23065464 DOI: 10.1007/s15010-012-0353-3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
40 Javadi S, Menias CO, Karbasian N, Shaaban A, Shah K, Osman A, Jensen CT, Lubner MG, Gaballah AH, Elsayes KM. HIV-related Malignancies and Mimics: Imaging Findings and Management. Radiographics 2018;38:2051-68. [PMID: 30339518 DOI: 10.1148/rg.2018180149] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
41 Cartlidge CR, U MRA, Alkhatib AMA, Taylor-Robinson SD. The utility of biomarkers in hepatocellular carcinoma: review of urine-based 1H-NMR studies - what the clinician needs to know. Int J Gen Med 2017;10:431-42. [PMID: 29225478 DOI: 10.2147/IJGM.S150312] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
42 Della Corte C, Aghemo A, Colombo M. Individualized hepatocellular carcinoma risk: The challenges for designing successful chemoprevention strategies. World J Gastroenterol 2013; 19(9): 1359-1371 [PMID: 23538741 DOI: 10.3748/wjg.v19.i9.1359] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
43 Bhimma R, Purswani MU, Kala U. Kidney disease in children and adolescents with perinatal HIV-1 infection. J Int AIDS Soc 2013;16:18596. [PMID: 23782479 DOI: 10.7448/IAS.16.1.18596] [Cited by in Crossref: 37] [Cited by in F6Publishing: 19] [Article Influence: 4.1] [Reference Citation Analysis]